Ptc Therapeutics (PTCT) Inventory (2017 - 2026)

Ptc Therapeutics' Inventory history runs 10 years deep, the most recent figure standing at $75.6 million for Q1 2026.

• In Q1 2026, Inventory rose 248.64% year-over-year to $75.6 million; the TTM figure through Mar 2026 stood at $75.6 million (up 248.64% YoY), while the FY2025 annual figure was $79.6 million, up 243.39% from the prior year.
• Inventory was $75.6 million for Q1 2026 at Ptc Therapeutics, down from $79.6 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $79.6 million in Q4 2025 to a low of $14.8 million in Q3 2022.
• Historically, Inventory has averaged $33.9 million across 5 years, with a median of $30.6 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Inventory slipped 27.89% in 2025, then jumped 248.64% in 2026.
• A 5-year view of Inventory shows it stood at $21.8 million in 2022, then surged by 40.21% to $30.6 million in 2023, then declined by 24.15% to $23.2 million in 2024, then jumped by 243.39% to $79.6 million in 2025, then dropped by 5.12% to $75.6 million in 2026.
• The last three Inventory figures came in at $75.6 million (Q1 2026), $79.6 million (Q4 2025), and $52.7 million (Q3 2025), per Business Quant data.